|
Lindesmith, Lisa C; Mallory, Michael L; Jones, Taylor A et al. (2017) Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination. J Infect Dis 215:984-991
|
|
Lindesmith, Lisa C; Beltramello, Martina; Swanstrom, Jesica et al. (2015) Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses. Open Forum Infect Dis 2:ofv084
|
|
Lindesmith, Lisa C; Ferris, Martin T; Mullan, Clancy W et al. (2015) Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial. PLoS Med 12:e1001807
|
|
Lindesmith, Lisa C; Donaldson, Eric F; Beltramello, Martina et al. (2014) Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope. J Virol 88:8826-42
|
|
Debbink, Kari; Lindesmith, Lisa C; Baric, Ralph S (2014) The state of norovirus vaccines. Clin Infect Dis 58:1746-52
|
|
Swanstrom, Jesica; Lindesmith, Lisa C; Donaldson, Eric F et al. (2014) Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects. J Virol 88:829-37
|
|
Vega, Everardo; Donaldson, Eric; Huynh, Jeremy et al. (2014) RNA populations in immunocompromised patients as reservoirs for novel norovirus variants. J Virol 88:14184-96
|
|
Debbink, Kari; Lindesmith, Lisa C; Donaldson, Eric F et al. (2014) Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses. J Virol 88:7256-66
|
|
Debbink, Kari; Lindesmith, Lisa C; Ferris, Martin T et al. (2014) Within-host evolution results in antigenically distinct GII.4 noroviruses. J Virol 88:7244-55
|
|
Kirby, A E; Shi, J; Montes, J et al. (2014) Disease course and viral shedding in experimental Norwalk virus and Snow Mountain virus infection. J Med Virol 86:2055-64
|
Showing the most recent 10 out of 33 publications
